Vantis Investment Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-30,300
Closed -$4.77M 26
2020
Q4
$4.77M Buy
+30,300
New +$4.47M 3.55% 13
2020
Q3
Sell
-30,300
Closed -$4.26M 23
2020
Q2
$4.26M Buy
+30,300
New +$4.42M 3.53% 14

Other funds holding JNJ

Vantis Investment Advisers's JNJ Position: Q1 2021 in Review

Vantis Investment Advisers sold out of Johnson & Johnson (JNJ) in Q1 2021, closing a stake of 30,300 shares — an estimated $4.77M sold.

Vantis Investment Advisers first reported a position in JNJ in Q2 2020 and held it in 2 quarters. The position peaked at $4.77M in Q4 2020. 3,317 funds tracked by Wall St. Rank hold JNJ as of Q1 2021.

  • Vantis Investment Advisers reported no remaining Johnson & Johnson position as of Q1 2021 after selling out during the quarter.
  • Vantis Investment Advisers sold 30,300 Johnson & Johnson shares in Q1 2021, an estimated $4.77M.
  • Vantis Investment Advisers first reported a position in Johnson & Johnson in Q2 2020 and held it in 2 quarters.
  • Vantis Investment Advisers's Johnson & Johnson position peaked at $4.77M in Q4 2020.
  • 3,317 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2021.

Based on Vantis Investment Advisers's 13F filing for Q1 2021, filed 13 May 2021.